Found: 79
Select item for more details and to access through your institution.
Grape Derived Polyphenols Attenuate Tau Neuropathology in a Mouse Model of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 2, p. 653, doi. 10.3233/JAD-2010-101074
- By:
- Publication type:
- Article
Carvedilol Reestablishes Long-Term Potentiation in a Mouse Model of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 21, n. 2, p. 649, doi. 10.3233/JAD-2010-100225
- By:
- Publication type:
- Article
nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing.
- Published in:
- 2009
- By:
- Publication type:
- journal article
nELAV Proteins Alteration in Alzheimer's Disease Brain: A Novel Putative Target for Amyloid-β Reverberating on AβPP Processing.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 2, p. 409, doi. 10.3233/JAD-2009-0967
- By:
- Publication type:
- Article
Grape Seed Polyphenolic Extract as a Potential Novel Therapeutic Agent in Tauopathies.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 2, p. 433, doi. 10.3233/JAD-2009-0969
- By:
- Publication type:
- Article
Heterogeneity in Red Wine Polyphenolic Contents Differentially Influences Alzheimer's Disease-type Neuropathology and Cognitive Deterioration.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 1, p. 59, doi. 10.3233/JAD-2009-0916
- By:
- Publication type:
- Article
Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus).
- Published in:
- Journal of Alzheimer's Disease, 2006, v. 10, n. 4, p. 417, doi. 10.3233/JAD-2006-10411
- By:
- Publication type:
- Article
From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists.
- Published in:
- Journal of Alzheimer's Disease, 2002, v. 4, n. 3, p. 193, doi. 10.3233/JAD-2002-4309
- By:
- Publication type:
- Article
Regulation of T helper 17 to regulatory T cell (Th17/Treg) as mediator of stress‐induced psychological impairment and cognitive deterioration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.068250
- By:
- Publication type:
- Article
Characterization of a mouse model as a predictive tool for human Post‐Acute Sequelae of Covid‐19.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.068207
- By:
- Publication type:
- Article
A novel gut microbiome therapeutic derived from dietary polyphenols attenuates neuroinflammation in vivo in a model of C9orf72‐mediated frontotemporal dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056490
- By:
- Publication type:
- Article
COVID‐19 and Alzheimer's disease: Meninges‐mediated neuropathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056418
- By:
- Publication type:
- Article
Role of SARS‐CoV‐2 in causing blood‐brain barrier leakage and microglial activation as a risk factor of cognitive deterioration in subjects at risk of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056183
- By:
- Publication type:
- Article
Role of diesel exhaust exposure in promoting Alzheimer's disease susceptibility by impairing glymphatic drainage of amyloid beta (aβ) and other toxic metabolites from the brain.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056165
- By:
- Publication type:
- Article
Causal effects of microglia‐mediated innate immune responses in the pathogenesis of c9orf72 frontotemporal dementia and amyotrophic lateral sclerosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.051865
- By:
- Publication type:
- Article
Diesel exhaust particle role on gut microbiome and onset of Alzheimer disease neuroinflammation: Health services research / Policy and plans.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046266
- By:
- Publication type:
- Article
Development of a functional 3D brain organoid with microvasculature and a blood‐brain barrier: Development of new models and analysis methods/novel assays and technologies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046214
- By:
- Publication type:
- Article
Defining the role of gut microbiota‐derived ketamine metabolites in Alzheimer's disease: Nonhuman/Target identification and validation studies: Inflammation and innate immunity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046152
- By:
- Publication type:
- Article
Development of a platform for the discovery of new Alzheimer's disease drugs targeting stress‐induced neuroinflammation: Nonhuman: Preclinical studies on APOE and neuroinflammation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046080
- By:
- Publication type:
- Article
A novel gut microbiome therapeutic derived from dietary polyphenols attenuates neuroinflammation in vivo in a model of c9orf72 mediated frontotemporal dementia: Nonhuman/Target identification and validation studies: Inflammation and innate immunity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046032
- By:
- Publication type:
- Article
Brain bioavailable microbiome derived flavonoid metabolite attenuates neuroinflammation in C9orf72 associated frontotemporal dementia: Nonhuman/Lead optimization studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046035
- By:
- Publication type:
- Article
Effect of polyphenol treatment for mild cognitive impairment (MCI) and diabetes: Human/Human trials: Nutraceuticals and non‐pharmacological interventions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044062
- By:
- Publication type:
- Article
P4‐691: TARGETING INFLAMMASOME ACTIVATION IN RESPONSE TO STRESS TO SUPPRESS ONSET AND PROGRESSION OF ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1596, doi. 10.1016/j.jalz.2019.09.056
- By:
- Publication type:
- Article
Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.
- Published in:
- Journal of Clinical Investigation, 2007, v. 117, n. 11, p. 3393, doi. 10.1172/JCI31547
- By:
- Publication type:
- Article
Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia.
- Published in:
- Disease Markers, 2006, v. 22, n. 1-2, p. 303
- By:
- Publication type:
- Article
Anxiolytic effects of NLRP3 inflammasome inhibition in a model of chronic sleep deprivation.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-020-01189-3
- By:
- Publication type:
- Article
Human microbiome collection.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30625-9
- By:
- Publication type:
- Article
CHARACTERIZATION OF NOVEL BIOAVAILABLE BIOACTIVE POLYPHENOLIC COMPOUNDS FOR PHARMACOLOGICAL PRESERVATION OF BLOOD BRAIN BARRIER FUNCTION IN ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P436, doi. 10.1016/j.jalz.2016.06.841
- By:
- Publication type:
- Article
REPURPOSING A DRUG FOR TREATMENT OF PROSTATE CANCER FOR PREVENTION OF DEMENTIA IN PARKINSON’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P179, doi. 10.1016/j.jalz.2016.06.310
- By:
- Publication type:
- Article
PROTECTIVE ROLES OF INTESTINAL MICROBIOTA IN ALZHEIMER’S DISEASE THROUGH MECHANISMS INVOLVING SHORT CHAIN FATTY ACIDS AND PHENOLIC ACIDS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P224, doi. 10.1016/j.jalz.2016.06.402
- By:
- Publication type:
- Article
NOVEL ROLE OF THE NEUROSPECIFIC SCFFBX2-E3-LIGASE IN MECHANISMS ASSOCIATED WITH THE PROMOTION OF SYNAPTIC PLASTICITY THROUGH RESCUE OF CAMP-CREB SIGNALING PATHWAY IN A MODEL OF ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P625, doi. 10.1016/j.jalz.2016.06.1251
- By:
- Publication type:
- Article
Intestinal microbiota-derived phenol acids are capable of accumulating in the brain and interfere with β-amyloid oligomerization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P838, doi. 10.1016/j.jalz.2015.06.1862
- By:
- Publication type:
- Article
Targeting multiple disease mechanisms for the treatment of Alzheimer’s disease with biosynthetic polyphenol metabolites and their precursor pro-drugs in vivo.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P158, doi. 10.1016/j.jalz.2015.07.091
- By:
- Publication type:
- Article
Preservation of synaptic plasticity and neuronal integrity in a mouse model of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P614, doi. 10.1016/j.jalz.2015.06.857
- By:
- Publication type:
- Article
Carvedilol reduces Aβ oligomerization and improves spatial memory in mouse models of Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Regulation of Forkhead Transcription Factor FoxO3a Contributes to Calorie Restriction-induced Prevention of Alzheimer's Disease-type Amyloid Neuropathology and Spatial Memory Deterioration.
- Published in:
- Annals of the New York Academy of Sciences, 2008, v. 1147, p. 335, doi. 10.1196/annals.1427.024
- By:
- Publication type:
- Article
Insulin Receptor Expression and Activity in the Brains of Nondiabetic Sporadic Alzheimer's Disease Cases.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Insulin Receptor Expression and Activity in the Brains of Nondiabetic Sporadic Alzheimer's Disease Cases.
- Published in:
- International Journal of Alzheimer's Disease, 2012, p. 1, doi. 10.1155/2012/321280
- By:
- Publication type:
- Article
Caloric Intake, Dietary Lifestyles, Macronutrient Composition, and Alzheimer' Disease Dementia.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Caloric Intake, Dietary Lifestyles, Macronutrient Composition, and Alzheimer' Disease Dementia.
- Published in:
- International Journal of Alzheimer's Disease, 2011, v. 2011, p. 1, doi. 10.4061/2011/806293
- By:
- Publication type:
- Article
Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049191
- By:
- Publication type:
- Article
S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10.
- Published in:
- PLoS ONE, 2009, v. 4, n. 1, p. 1, doi. 10.1371/journal.pone.0004183
- By:
- Publication type:
- Article
Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease.
- Published in:
- Journal of Neuroscience Research, 1999, v. 57, n. 3, p. 295, doi. 10.1002/(SICI)1097-4547(19990801)57:3<295::AID-JNR1>3.0.CO;2-0
- By:
- Publication type:
- Article
Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions.
- Published in:
- Journal of Neuroscience Research, 1998, v. 54, n. 1, p. 1, doi. 10.1002/(SICI)1097-4547(19981001)54:1<1::AID-JNR1>3.0.CO;2-M
- By:
- Publication type:
- Article
Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity.
- Published in:
- Journal of Cellular Biochemistry, 1999, v. 73, n. 3, p. 303, doi. 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2
- By:
- Publication type:
- Article
Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo.
- Published in:
- Journal of Neuroinflammation, 2008, v. 5, p. 1, doi. 10.1186/1742-2094-5-5
- By:
- Publication type:
- Article
Cyclooxygenase as a Target for the Antiamyloidogenic Activities of Nonsteroidal Anti-Inflammatory Drugs in Alzheimer's Disease.
- Published in:
- NeuroSignals (Karger AG), 2002, v. 11, n. 5, p. 293, doi. 10.1159/000067428
- By:
- Publication type:
- Article